AAAAAA

   
Results: 1-8 |
Results: 8
Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel
Authors: Penson, RT Kronish, K Duan, Z Feller, AJ Stark, P Cook, SE Duska, LR Fuller, AF Goodman, AK Nikrui, N MacNeill, KM Matulonis, UA Preffer, FI Seiden, MV
Citation: Rt. Penson et al., Cytokines IL-1 beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel, INT J GYN C, 10(1), 2000, pp. 33-41
Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: A review of fifteen cases
Authors: del Carmen, MG McIntyre, JF Fuller, AF Nikrui, N Goodman, A
Citation: Mg. Del Carmen et al., Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: A review of fifteen cases, GYNECOL ONC, 79(3), 2000, pp. 457-462
Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer
Authors: Cook, S Penson, R Duska, L Nikrui, N Goodman, A Fuller, A Seiden, M
Citation: S. Cook et al., Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer, GYNECOL ONC, 77(1), 2000, pp. 48-54
Borderline tumors of the ovary: Correlation of frozen and permanent histopathologic diagnosis
Authors: Houck, K Nikrui, N Duska, L Chang, YC Fuller, AF Bell, D Goodman, A
Citation: K. Houck et al., Borderline tumors of the ovary: Correlation of frozen and permanent histopathologic diagnosis, OBSTET GYN, 95(6), 2000, pp. 839-843
Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity
Authors: Gong, JL Nikrui, N Chen, DS Koido, S Wu, ZK Tanaka, Y Cannistra, S Avigan, D Kufe, D
Citation: Jl. Gong et al., Fusions of human ovarian carcinoma cells with autologous or allogeneic dendritic cells induce antitumor immunity, J IMMUNOL, 165(3), 2000, pp. 1705-1711
A phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer
Authors: Duska, LR Penson, R Supko, JG Finkelstein, DM Makastorsis, T Gallagher, J Borden, K Goodman, A Fuller, AF Nikrui, N Seiden, MV
Citation: Lr. Duska et al., A phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer, CLIN CANC R, 5(6), 1999, pp. 1299-1305
Predictors of recurrence in surgical stage II endometrial adenocarcinoma
Authors: Feltmate, CM Duska, LR Chang, YC Flynn, CE Nikrui, N Kiggundu, E Goodman, A Fuller, AF McIntyre, JF
Citation: Cm. Feltmate et al., Predictors of recurrence in surgical stage II endometrial adenocarcinoma, GYNECOL ONC, 73(3), 1999, pp. 407-411
Epithelial ovarian carcinoma in the reproductive age group
Authors: Duska, LR Chang, YC Flynn, CE Chen, AH Goodman, A Fuller, AF Nikrui, N
Citation: Lr. Duska et al., Epithelial ovarian carcinoma in the reproductive age group, CANCER, 85(12), 1999, pp. 2623-2629
Risultati: 1-8 |